US Stock MarketDetailed Quotes

BCAX Bicara Therapeutics

Watchlist
  • 17.590
  • +0.990+5.96%
Close Dec 20 16:00 ET
  • 17.590
  • 0.0000.00%
Post 16:20 ET
957.17MMarket Cap-16.09P/E (TTM)

Bicara Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Bicara Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--------
--------

Unlock Free Earnings Estimates

Bicara Therapeutics Earnings Reports

  • Bicara Therapeutics | 10-Q: Quarterly report

    Nov 12 16:09 ET

  • Bicara Therapeutics | 8-K: Bicara Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update

    Nov 12 13:44 ET

    • Trending US Stocks
    Best Growth Stocks Best Growth Stocks

    Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

    Symbol Mini Chart % Chg
    Ermenegildo Zegna NV
    ZGN
    +6.16%
    DexCom
    DXCM
    +5.57%
    New Fortress Energy
    NFE
    +5.37%
    Workday
    WDAY
    +2.33%
    eBay
    EBAY
    +1.66%

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Dec 6, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Investment Theme Recent IPOs
    Recent IPOs
    Intraday+0.71%